91桃色

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review   
  • Clin Pharmacol Biopharm; 2022, Vol 11(1): 248
  • DOI: 10.4172/2167-065X.1000248

Evalution of Anti-inflammatory & Immunosuppressant Activity of Dexamethasone

Rutuja Thopate*
Shivajirao Pawar College of Pharmacy Pachegaon, Tal-Newasa, Ahmednagar, Maharashtra, India
*Corresponding Author : Rutuja Thopate, Shivajirao Pawar College of Pharmacy Pachegaon, Tal-Newasa, Ahmednagar, Maharashtra, India, Email: rutujathopate6419@gmail.com

Received Date: Jan 19, 2022 / Accepted Date: Jan 29, 2022 / Published Date: Feb 05, 2022

Abstract

Glucocorticoids are powerful anti-inflammatory compounds and widely used in the therapy of allergic diseases. This study aimed to determine the effect of dexamethasone (Dex) on the immunomodulatory function in vitro and in vivo. The development of in vitro methods is important in drug discovery process due to the restriction of animal use in the pharmacological screening process. Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can be administered without abrogating the efforts of immunotherapy. The purpose of this study was to evaluate the impact of dexamethasone on lymphocyte activation and proliferation during checkpoint blockade to provide guidance for corticosteroid use while immunotherapy is being implemented as a cancer treatment.

Citation: Thopate R (2022) Evalution of Anti-Inflammatory & Immunosuppressant Activity of Dexamethasone. Clin Pharmacol Biopharm 11: 248. Doi: 10.4172/2167-065X.1000248

Copyright: © 2022 Thopate R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Tools
Article Usage
  • Total views: 2681
  • [From(publication date): 0-2022 - Jun 19, 2025]
  • Breakdown by view type
  • HTML page views: 2145
  • PDF downloads: 536
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top